Bailard’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-10,434
| Closed | -$195K | – | 752 |
|
|
2021
Q3 | $195K | Buy |
+10,434
| New | +$195K | 0.01% | 685 |
|
|
2021
Q2 | – | Sell |
-81,934
| Closed | -$2.32M | – | 730 |
|
|
2021
Q1 | $2.32M | Buy |
81,934
+42,000
| +105% | +$1.19M | 0.09% | 185 |
|
|
2020
Q4 | $1.3M | Buy |
39,934
+3,100
| +8% | +$101K | 0.06% | 188 |
|
|
2020
Q3 | $1.13M | Sell |
36,834
-9,800
| -21% | -$300K | 0.06% | 190 |
|
|
2020
Q2 | $760K | Sell |
46,634
-1,800
| -4% | -$29.3K | 0.04% | 221 |
|
|
2020
Q1 | $482K | Buy |
48,434
+6,000
| +14% | +$59.7K | 0.03% | 230 |
|
|
2019
Q4 | $583K | Buy |
42,434
+5,334
| +14% | +$73.3K | 0.03% | 250 |
|
|
2019
Q3 | $563K | Sell |
37,100
-1,400
| -4% | -$21.2K | 0.03% | 251 |
|
|
2019
Q2 | $758K | Hold |
38,500
| – | – | 0.05% | 235 |
|
|
2019
Q1 | $639K | Buy |
38,500
+8,500
| +28% | +$141K | 0.04% | 261 |
|
|
2018
Q4 | $421K | Hold |
30,000
| – | – | 0.03% | 337 |
|
|
2018
Q3 | $525K | Hold |
30,000
| – | – | 0.03% | 362 |
|
|
2018
Q2 | $546K | Hold |
30,000
| – | – | 0.03% | 342 |
|
|
2018
Q1 | $563K | Sell |
30,000
-3,805
| -11% | -$71.4K | 0.04% | 295 |
|
|
2017
Q4 | $517K | Buy |
+33,805
| New | +$517K | 0.03% | 309 |
|